These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 32617963)

  • 41. An overview on the identification of MAIT cell antigens.
    Kjer-Nielsen L; Corbett AJ; Chen Z; Liu L; Mak JY; Godfrey DI; Rossjohn J; Fairlie DP; McCluskey J; Eckle SB
    Immunol Cell Biol; 2018 Jul; 96(6):573-587. PubMed ID: 29656544
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mucosal-Associated Invariant T Cells Redistribute to the Peritoneal Cavity During Spontaneous Bacterial Peritonitis and Contribute to Peritoneal Inflammation.
    Ibidapo-Obe O; Stengel S; Köse-Vogel N; Quickert S; Reuken PA; Busch M; Bauer M; Stallmach A; Bruns T
    Cell Mol Gastroenterol Hepatol; 2020; 9(4):661-677. PubMed ID: 31954178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical relevance of circulating mucosal-associated invariant T cell levels and their anti-cancer activity in patients with mucosal-associated cancer.
    Won EJ; Ju JK; Cho YN; Jin HM; Park KJ; Kim TJ; Kwon YS; Kee HJ; Kim JC; Kee SJ; Park YW
    Oncotarget; 2016 Nov; 7(46):76274-76290. PubMed ID: 27517754
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mucosal-Associated Invariant T Cells in Autoimmune Diseases.
    Chiba A; Murayama G; Miyake S
    Front Immunol; 2018; 9():1333. PubMed ID: 29942318
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mucosal-Associated Invariant T Cell Dysregulation Correlates With Conjugated Bilirubin Level in Chronic HBV Infection.
    Liu Y; Zhu P; Wang W; Tan X; Liu C; Chen Y; Pei R; Cheng X; Wu M; Guo Q; Liang H; Liang Z; Liu J; Xu Y; Wu X; Weng X
    Hepatology; 2021 May; 73(5):1671-1687. PubMed ID: 33080074
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IL-7 primes IL-17 in mucosal-associated invariant T (MAIT) cells, which contribute to the Th17-axis in ankylosing spondylitis.
    Gracey E; Qaiyum Z; Almaghlouth I; Lawson D; Karki S; Avvaru N; Zhang Z; Yao Y; Ranganathan V; Baglaenko Y; Inman RD
    Ann Rheum Dis; 2016 Dec; 75(12):2124-2132. PubMed ID: 27165176
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Persistent reduction of mucosal-associated invariant T cells in primary biliary cholangitis.
    Setsu T; Yamagiwa S; Tominaga K; Kimura N; Honda H; Kamimura H; Tsuchiya A; Takamura M; Terai S
    J Gastroenterol Hepatol; 2018 Jun; 33(6):1286-1294. PubMed ID: 29266628
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Title of article: Mucosal-associated invariant T cells in lung diseases.
    Wen X; Zhang X; Nian S; Wei G; Guo X; Yu H; Xie X; Ye Y; Yuan Q
    Int Immunopharmacol; 2021 May; 94():107485. PubMed ID: 33647824
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mucosal-associated invariant T-cells: new players in anti-bacterial immunity.
    Ussher JE; Klenerman P; Willberg CB
    Front Immunol; 2014; 5():450. PubMed ID: 25339949
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MAIT cells: programmed in the thymus to mediate immunity within tissues.
    Lantz O; Legoux F
    Curr Opin Immunol; 2019 Jun; 58():75-82. PubMed ID: 31141764
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites.
    Sakala IG; Kjer-Nielsen L; Eickhoff CS; Wang X; Blazevic A; Liu L; Fairlie DP; Rossjohn J; McCluskey J; Fremont DH; Hansen TH; Hoft DF
    J Immunol; 2015 Jul; 195(2):587-601. PubMed ID: 26063000
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Th1 bias of liver mucosal-associated invariant T cells promotes hepatic gluconeogenesis in type 2 diabetes mellitus.
    Tang W; Ge K; Shen L; Wang H; Feng W; Sun X; Chu X; Zhu D; Yin H; Bi Y
    Diabetes Metab Res Rev; 2023 May; 39(4):e3620. PubMed ID: 36738300
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Critical Role for Mucosal-Associated Invariant T Cells as Regulators and Therapeutic Targets in Systemic Lupus Erythematosus.
    Murayama G; Chiba A; Suzuki H; Nomura A; Mizuno T; Kuga T; Nakamura S; Amano H; Hirose S; Yamaji K; Suzuki Y; Tamura N; Miyake S
    Front Immunol; 2019; 10():2681. PubMed ID: 31849932
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tissue-resident mucosal-associated invariant T (MAIT) cells in the human kidney represent a functionally distinct subset.
    Terpstra ML; Remmerswaal EBM; van der Bom-Baylon ND; Sinnige MJ; Kers J; van Aalderen MC; Geerlings SE; Bemelman FJ
    Eur J Immunol; 2020 Nov; 50(11):1783-1797. PubMed ID: 32652598
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuropathologic, phenotypic and functional analyses of Mucosal Associated Invariant T cells in Multiple Sclerosis.
    Salou M; Nicol B; Garcia A; Baron D; Michel L; Elong-Ngono A; Hulin P; Nedellec S; Jacq-Foucher M; Le Frère F; Jousset N; Bourreille A; Wiertlewski S; Soulillou JP; Brouard S; Nicot AB; Degauque N; Laplaud DA
    Clin Immunol; 2016 May; 166-167():1-11. PubMed ID: 27050759
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MAITabolism
    Kedia-Mehta N; Hogan AE
    Front Immunol; 2022; 13():1108071. PubMed ID: 36741413
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intra-Hepatic Depletion of Mucosal-Associated Invariant T Cells in Hepatitis C Virus-Induced Liver Inflammation.
    Bolte FJ; O'Keefe AC; Webb LM; Serti E; Rivera E; Liang TJ; Ghany M; Rehermann B
    Gastroenterology; 2017 Nov; 153(5):1392-1403.e2. PubMed ID: 28780074
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mucosal-associated invariant T cells and disease.
    Toubal A; Nel I; Lotersztajn S; Lehuen A
    Nat Rev Immunol; 2019 Oct; 19(10):643-657. PubMed ID: 31308521
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MR1-Independent Activation of Human Mucosal-Associated Invariant T Cells by Mycobacteria.
    Suliman S; Murphy M; Musvosvi M; Gela A; Meermeier EW; Geldenhuys H; Hopley C; Toefy A; Bilek N; Veldsman A; Hanekom WA; Johnson JL; Boom WH; Obermoser G; Huang H; Hatherill M; Lewinsohn DM; Nemes E; Scriba TJ
    J Immunol; 2019 Dec; 203(11):2917-2927. PubMed ID: 31611259
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MAIT cell-mediated cytotoxicity: Roles in host defense and therapeutic potentials in infectious diseases and cancer.
    Rudak PT; Choi J; Haeryfar SMM
    J Leukoc Biol; 2018 Sep; 104(3):473-486. PubMed ID: 29668066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.